-
Magic Pharmaceuticals intends to transfer a 30.16 per cent stake in Jilin Kangzheng
Time of Update: 2021-03-07
, Magic Pharmaceuticals announced today that its wholly-owned subsidiary, Magic Pharmaceuticals, intends to transfer its 30.16 percent stake in Jilin Kangzheng, the controlling sun company.
-
National volume procurement after the arms enterprises can be such a transformation
Time of Update: 2021-03-07
2, the business model of armed enterprises urgently need to break through Specialized medical supplies operating companies, or large pharmaceutical companies of the medical equipment department, is operating all kinds of medical supplies of the main body.
-
This medical device material was invested by the giant in a heavy warehouse. New changes in the industry have arrived.
Time of Update: 2021-03-07
DuPont's healthcare business keeps up with intelligent trends and customer needs in the medical device industry, providing safe, comfortable, convenient and effective diagnosis, monitoring and treatment for timely care through a wide range of specialty medical adhesives and elastomer products to support the development trend of connected and wearable devices and enhance the patient experience.
-
Beijing: Strictly control drug sales in pharmacies and encourage pharmacies to split retail sales
Time of Update: 2021-03-07
"Notice" clearly, all units to strictly implement the GSP requirements, regulate the operation of pharmaceutical retail enterprises, strengthen the management of the sale of prescription drugs, must be sold by prescription prescription drugs by prescription, practicing pharmacists should be on duty, to perform the duties of the review.
-
AstraZenecom's $1 billion inhaler emergency?
Time of Update: 2021-03-07
Prior to this, Shijiazhuang four drugs, four Trump Reiter pharmaceutical industry, health yuan seaside pharmaceutical | health yuan pharmaceutical group and other 6 enterprises submitted imitation 4 categories of listing applications in the review and approval (in the drug review center).
-
Large-scale pharmaceutical industry park project settled in Kunming high-tech zone
Time of Update: 2021-03-07
It can be said that the landing of this large-scale pharmaceutical industry park project has positively responded to the implementation of Yunnan Province biomedicine and large health industry "147" action plan, Kunming High-tech Zone "13th Five-Year Plan" main development of biomedicine and other three major industrial development plans.
-
The third batch of collections will come to an end, and the west is not the market or will be reconstructed accordingly
Time of Update: 2021-03-07
According to the "National Drug Centralized Procurement Results Table (GY-YD2020-1)" shows that Qilu Pharmaceuticals from the theoretical point of view of the next year in the medical institutions to sell less than 5 million pieces of Xidi Nafei, less than 10% of Baiyunshan Jingo 2019 sales, according to the selected purchase price, its market sales of less than 20 million yuan, but its actual market will be much larger than this, and its impact will be deeper.
-
Huahai Pharmaceuticals' first three quarters of results are soaring sales costs are decreasing
Time of Update: 2021-03-07
a number of pharmaceutical companies, sales costs are falling sharply the performance of well-known pharmaceutical companies October 20, Huahai Pharmaceuticals released the first three quarters
-
The three major pharmaceutical central enterprises have all entered the bureau of the blood products field pattern or change
Time of Update: 2021-03-07
If this merger is finally completed, the industry believes that with the help of China Resources Pharmaceuticals' state-owned background and predictable government resources, the blood products field may be changing, Boya Bio is expected to become the fifth "thousand tons" plasma company after Hualan Biology, Temple of Heaven Biology, Shanghai Lais, Taibang Bio.
-
Several giant drugstore chains with revenues of more than 20 billion yuan are coming
Time of Update: 2021-03-07
of giant pharmacies with revenues of more than $20 billion are coming In the third quarter of 2020, China National Pharmaceuticals reported a net cash increase of RMB237,928.71 million, or 44,656.29 percent, over the same period last year.
-
Genesis announced the completion of a $21 million round B financing
Time of Update: 2021-03-07
Genesis has introduced overseas clinical products to China and partnered with overseas partners in global multi-center clinical trials, while developing best-in-class drugs and has launched innovative drug projects for four targets.
-
From next year, these drugs will no longer be reimbursed by Medicare pharmacies
Time of Update: 2021-03-07
, Jiangsu Provincial Medical Security Bureau, Jiangsu Provincial Human Resources and Social Security Department jointly issued "on the publication of basic medical insurance, work injury insurance and
-
600 billion prescription drugs transferred online to split whose cake
Time of Update: 2021-03-07
On November 14th, a number of Chinese pharmacy chain entrepreneurs, through the China Pharmaceutical Materials Association, provided the media with a "communication material on the proposal to vigorously strengthen the safety supervision of the online sale of prescription drugs".
-
Large-scale overcapacity Biodiagnosis may become the next air port
Time of Update: 2021-03-07
1, large-scale overcapacity November 12, 2020 Tiancat Double Eleven global carnival season has come to an end, the analysis data seem to be foreshadowing the direction of China's consumer industry, according to Cypress Blue device observation, "Double Eleven" activities, Tmall mask sales decreased by 76.24 percent compared to the outbreak period; What is the current domestic production capacity of protective materials and where will the market develop?
-
China Resources Pharmaceuticals intends to acquire a controlling stake in Boya Biopharmaceutical Group
Time of Update: 2021-03-07
China Resources Pharmaceutical Holdings intends to acquire a controlling stake in the target company, and the terms of the proposed acquisition will not be implemented until further negotiations between China Resources Pharmaceutical Holdings and the seller.
-
Health Insurance Bureau: Keep an eye on hospital health insurance loopholes, flight inspection has been targeted
Time of Update: 2021-03-07
At the same time, in 2019, the State Health Insurance Administration sent 69 flight inspection teams to 30 provinces across the country to carry out on-site inspections and interviews with 177 designated medical institutions, and found that the suspected illegal funds amounted to 2.232 billion yuan.
-
Multi-test water online medical reimbursement "Internet plus medical" crack to see a doctor difficult
Time of Update: 2021-03-07
Fu Hongqiao, an associate researcher at Peking University's School of Public Health, said that the new "Internet Plus" health care regulations recently issued by the State Administration of Health Insurance do not discriminate between hospitals and third-party platforms, and clarify the path to the realization of medical insurance payments for third-party Internet medical platforms that rely on physical medical institutions.
-
Drug traceability related policies are initiated in many provinces affecting all pharmacies
Time of Update: 2021-03-07
In addition, on September 21, Hebei Provincial Drug Administration issued a notice, has officially launched the province's Chinese medicine tablets traceability work, 20 production enterprises and 77 franchise enterprises have been included in the retrospective scope for the first time.
-
Crystal Bio completed a $50 million round A financing
Time of Update: 2021-03-07
The company will use the funds to build a globally innovative research and development pipeline and a core eye drug innovation technology platform to meet the medical needs of patients in China and around the world for eye diseases.
-
The results of the winning bid of the three provincial alliances, which reduced the price by 90.35%, were announced
Time of Update: 2021-03-07
basically no small business winning bid 1, a maximum price reduction of 90.35 percent, a number of well-known arms enterprises won the bid September 5, Chongqing Municipal Health Insurance Bureau
